Current Research Interests
Dr. Begg has long-standing interests in cancer epidemiology, health services research, clinical trials, and the statistical methods that support scientific studies in these disciplines. Currently his work is focused on two areas. In the first, he is developing statistical techniques for clonality assessment, used to distinguish independent second primary cancers from metastases on the basis of the somatic molecular profiles of the tumors. In the second area of investigation, he is developing methods for using somatic profiles of tumors to make inferences about the etiologic heterogeneity of tumor sub-types. He collaborates closely with various other members of the department on these projects, notably Audrey Mauguen, Irina Ostrovnaya, Venkatraman Seshan, Ronglai Shen and Emily Zabor. Dr. Begg also currently serves as Editor-in-Chief of the international scholarly journal Clinical Trials, the journal of the Society for Clinical Trials.
Visit PubMed for a full listing of Colin Begg’s journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Colin Begg discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures
